Rapid Communication
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Aug 21, 2008; 14(31): 4915-4922
Published online Aug 21, 2008. doi: 10.3748/wjg.14.4915
Table 4 Relationship between microvessel density and clinicopathological factors in HCC
Microvessel count > 178/mm2/ ≤ 178/mm2P
Pretreatment
No (n = 98)53/451.0
Yes (n = 30)16/14
Liver damage
A (n = 102)54/480.969
B (n = 26)15/11
Background liver
Normal liver (n = 7)3/40.459
Chronic hepatitis (n = 75)38/37
Cirrhosis (n =46)28/18
Viral status
Hepatitis virus B (n = 50)32/180.152
Hepatitis virus C (n = 61)31/30
Both hepatitis virus B and C (n = 4)2/2
Non-B, non-C (n = 13)4/9
Number of tumors
Solitary (n = 92)50/421.0
Multiple (n =36)19/17
Tumor size
< 3 cm (n = 31)15/160.371
3-5 cm (n = 49)24/25
> 5 cm (n = 48)30/18
Macroscopic finding1
SN (n = 37)16/210.207
SNEG (n = 39)25/14
CMN (n = 52)28/24
Vascular involvement
No (n = 83)42/410.476
Yes (n = 45)27/18
Histopathological differentiation
Well (n = 19)12/70.437
Moderately (n = 97)55/42
Poorly (n = 6)2/4
Japan tumor-node-metastasis stage2
I (n = 14)5/90.542
II (n = 51)27/25
III (n = 44)25/19
VI-A (n = 19)12/7
Recurrence
No (n = 32)16/160.386
Yes (n = 96)53/43